CLS: Electrophysiology

Question 1

True or false: Continuous monitoring for AF superior to usual care in reducing stroke or systemic embolism

Answer 1

False

Question 3

Treating device detected AF:
value in short duration vs median duration (1.5 hours)

Answer 3

short duration: no difference but more bleeding risk

median duration (1.5 hours): apixaban treatment in patients with subclinical AF reduced severe strokes at the price of an increased risk of nonfatal bleeding.